{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:22:52Z","timestamp":1791246172691,"version":"4.1.0"},"reference-count":120,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002570"],"award-info":[{"award-number":["G1002570"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1136\/bjophthalmol-2015-308329","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T03:24:54Z","timestamp":1458617094000},"page":"1322-1331","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Genetic manipulation for inherited neurodegenerative diseases: myth or reality?"],"prefix":"10.1136","volume":"100","author":[{"given":"Patrick","family":"Yu-Wai-Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-308329-1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrneurol.2012.148","article-title":"Whole-genome and whole-exome sequencing in neurological diseases","volume":"8","author":"Foo","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Genomic medicine: Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-3","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S1474-4422(08)70241-2","article-title":"Genome-wide association studies in neurological disorders","volume":"7","author":"Sim\u00f3n-S\u00e1nchez","year":"2008","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1212\/WNL.0000000000001995","article-title":"Prevalence of neurogenetic disorders in the North of England","volume":"85","author":"Bargiela","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/bjophthalmol-2015-308329-5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/mt.2012.280","article-title":"A Comprehensive review of retinal gene therapy","volume":"21","author":"Boye","year":"2013","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.preteyeres.2012.09.001","article-title":"Clinical applications of retinal gene therapy","volume":"32","author":"Lipinski","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/gt.2011.161","article-title":"Gene supplementation therapy for recessive forms of inherited retinal dystrophies","volume":"19","author":"Smith","year":"2012","journal-title":"Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/gt.2011.172","article-title":"Gene-based therapies for dominantly inherited retinopathies","volume":"19","author":"Farrar","year":"2012","journal-title":"Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/hum.2010.140","article-title":"AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa","volume":"22","author":"Mao","year":"2011","journal-title":"Hum Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-10","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bph.12330","article-title":"Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy","volume":"170","author":"Guzman-Aranguez","year":"2013","journal-title":"Br J Pharmacol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nm0898-967","article-title":"Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa","volume":"4","author":"Lewin","year":"1998","journal-title":"Nat Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-12","doi-asserted-by":"crossref","first-page":"11488","DOI":"10.1073\/pnas.210319397","article-title":"Ribozyme rescue of photoreceptor cells in P23H transgenic rats: Long-term survival and late-stage therapy","volume":"97","author":"LaVail","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/bjophthalmol-2015-308329-13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2005.03.028","article-title":"Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach","volume":"12","author":"Kiang","year":"2005","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/mt.2008.301","article-title":"Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy","volume":"17","author":"Chadderton","year":"2009","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrneurol.2013.56","article-title":"Progress in gene therapy for neurological disorders","volume":"9","author":"Simonato","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.3427","article-title":"Targeting neurons and photons for optogenetics","volume":"16","author":"Packer","year":"2013","journal-title":"Nat Neurosci"},{"key":"key-10.1136\/bjophthalmol-2015-308329-17","doi-asserted-by":"crossref","first-page":"177ps5","DOI":"10.1126\/scitranslmed.3003101","article-title":"Optogenetics and translational medicine","volume":"5","author":"Chow","year":"2013","journal-title":"Sci Transl Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.preteyeres.2014.08.001","article-title":"Vector platforms for gene therapy of inherited retinopathies","volume":"43","author":"Trapani","year":"2014","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/156720111795256174","article-title":"Non-viral nucleic acid delivery: key challenges and future directions","volume":"8","author":"Elsabahy","year":"2011","journal-title":"Curr Drug Deliv"},{"key":"key-10.1136\/bjophthalmol-2015-308329-20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.visres.2007.07.027","article-title":"Versatility of AAV vectors for retinal gene transfer","volume":"48","author":"Surace","year":"2008","journal-title":"Vision Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-21","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1089\/hum.2012.123","article-title":"Gene therapy of inherited retinopathies: a long and successful road from viral vectors to patients","volume":"23","author":"Colella","year":"2012","journal-title":"Hum Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.gt.3301574","article-title":"In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium","volume":"8","author":"Bainbridge","year":"2001","journal-title":"Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.gt.3302570","article-title":"Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors\u2014design, biosafety, and production","volume":"12","author":"Sinn","year":"2005","journal-title":"Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","article-title":"Effective gene therapy with nonintegrating lentiviral vectors","volume":"12","author":"Y\u00e1\u00f1ez-Mu\u00f1oz","year":"2006","journal-title":"Nat Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.preteyeres.2008.05.003","article-title":"Leber congenital amaurosis: genes, proteins and disease mechanisms","volume":"27","author":"den Hollander","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.preteyeres.2010.03.004","article-title":"The molecular basis of human retinal and vitreoretinal diseases","volume":"29","author":"Berger","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ng1097-139","article-title":"Mutations in RPE65 cause Leber's congenital amaurosis","volume":"17","author":"Marlhens","year":"1997","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ng1097-194","article-title":"Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy","volume":"17","author":"Gu","year":"1997","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","article-title":"Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness","volume":"12","author":"Acland","year":"2005","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-32","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber's congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-33","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber's congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/hum.2008.107","article-title":"Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase i trial","volume":"19","author":"Hauswirth","year":"2008","journal-title":"Hum Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-35","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/bjophthalmol-2015-308329-36","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/bjophthalmol-2015-308329-37","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-38","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-39","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMe1503419","article-title":"Long-term effects of retinal gene therapy in childhood blindness","volume":"372","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-40","doi-asserted-by":"crossref","first-page":"a017293","DOI":"10.1101\/cshperspect.a017293","article-title":"Gene therapy for choroideremia using an adeno-associated viral (AAV) vector","volume":"5","author":"Barnard","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng0592-109","article-title":"Aberrant splicing of the CHM gene is a significant cause of choroideremia","volume":"1","author":"Sankila","year":"1992","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.8380507","article-title":"Retinal degeneration in choroideremia: deficiency of Rab geranylgeranyl transferase","volume":"259","author":"Seabra","year":"1993","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-308329-43","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1167\/iovs.09-4892","article-title":"Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia","volume":"51","author":"Tolmachova","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-308329-44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00109-013-1006-4","article-title":"Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo","volume":"91","author":"Tolmachova","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"key-10.1136\/bjophthalmol-2015-308329-45","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.2014.37","article-title":"Treatment strategies for inherited optic neuropathies: past, present and future","volume":"28","author":"Yu-Wai-Man","year":"2014","journal-title":"Eye (Lond)"},{"key":"key-10.1136\/bjophthalmol-2015-308329-47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/2441","article-title":"A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)","volume":"20","author":"Inoue","year":"1998","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-48","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/hmg\/7.13.2021","article-title":"Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein","volume":"7","author":"Strom","year":"1998","journal-title":"Hum Mol Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneurol.2014.228","article-title":"Disturbed mitochondrial dynamics and neurodegenerative disorders","volume":"11","author":"Burt\u00e9","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-52","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/brain\/aws303","article-title":"The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse","volume":"135","author":"Sarzi","year":"2012","journal-title":"Brain"},{"key":"key-10.1136\/bjophthalmol-2015-308329-53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/eye.2011.2","article-title":"Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations","volume":"25","author":"Yu-Wai-Man","year":"2011","journal-title":"Eye"},{"key":"key-10.1136\/bjophthalmol-2015-308329-55","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with Leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-308329-56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrneurol.2013.129","article-title":"New treatments for mitochondrial disease-no time to drop our standards","volume":"9","author":"Pfeffer","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-59","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.10354","article-title":"Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathy","volume":"52","author":"Guy","year":"2002","journal-title":"Ann Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-60","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbamcr.2008.04.018","article-title":"The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes","volume":"1783","author":"Bonnet","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key-10.1136\/bjophthalmol-2015-308329-61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajhg.2008.08.013","article-title":"Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction","volume":"83","author":"Ellouze","year":"2008","journal-title":"Am J Hum Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-62","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1167\/iovs.08-3214","article-title":"Efficiency and Safety of AAV-mediated gene delivery of the human ND4 complex i subunit in the mouse visual system","volume":"50","author":"Guy","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-308329-63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/nar\/gkq769","article-title":"Allotopic expression of mitochondrial-encoded genes in mammals: achieved goal, undemonstrated mechanism or impossible task?","volume":"39","author":"Perales-Clemente","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-64","doi-asserted-by":"crossref","first-page":"20065","DOI":"10.1073\/pnas.1217113109","article-title":"Mouse mtDNA mutant model of Leber hereditary optic neuropathy","volume":"109","author":"Lin","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/bjophthalmol-2015-308329-65","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/archopht.125.2.268","article-title":"Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation","volume":"125","author":"Qi","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-66","doi-asserted-by":"crossref","first-page":"14250","DOI":"10.1074\/jbc.M600922200","article-title":"In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease","volume":"281","author":"Seo","year":"2006","journal-title":"J Biol Chem"},{"key":"key-10.1136\/bjophthalmol-2015-308329-67","doi-asserted-by":"crossref","first-page":"e11472","DOI":"10.1371\/journal.pone.0011472","article-title":"Successful amelioration of mitochondrial optic neuropathy using the yeast NDI1 gene in a rat animal model","volume":"5","author":"Marella","year":"2010","journal-title":"PLoS ONE"},{"key":"key-10.1136\/bjophthalmol-2015-308329-68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ejhg.2012.112","article-title":"Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy","volume":"21","author":"Chadderton","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrneurol.2014.226","article-title":"The ongoing pursuit of neuroprotective therapies in Parkinson disease","volume":"11","author":"Athauda","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-70","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/mthe.2001.0473","article-title":"Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa","volume":"4","author":"Liang","year":"2001","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-71","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1006\/mthe.2001.0498","article-title":"Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa","volume":"4","author":"McGee Sanftner","year":"2001","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-72","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1523\/JNEUROSCI.23-10-04164.2003","article-title":"Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage","volume":"23","author":"Okoye","year":"2003","journal-title":"J Neurosci"},{"key":"key-10.1136\/bjophthalmol-2015-308329-73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","article-title":"Functional recovery in Parkinsonian monkeys treated with GDNF","volume":"380","author":"Gash","year":"1996","journal-title":"Nature"},{"key":"key-10.1136\/bjophthalmol-2015-308329-74","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.mt.6300010","article-title":"Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease","volume":"15","author":"Gasmi","year":"2007","journal-title":"Mol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-75","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S1474-4422(10)70254-4","article-title":"Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial","volume":"9","author":"Marks","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-76","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.cell.2011.12.004","article-title":"The microbial opsin family of optogenetic tools","volume":"147","author":"Zhang","year":"2011","journal-title":"Cell"},{"key":"key-10.1136\/bjophthalmol-2015-308329-77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.2.7.4","article-title":"Proceedings of the first international optogenetic therapies for vision symposium","volume":"2","author":"Francis","year":"2013","journal-title":"Transl Vis Sci Technol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/gt.2011.155","article-title":"Optogenetic therapy for retinitis pigmentosa","volume":"19","author":"Busskamp","year":"2012","journal-title":"Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-79","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2006.02.026","article-title":"Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration","volume":"50","author":"Bi","year":"2006","journal-title":"Neuron"},{"key":"key-10.1136\/bjophthalmol-2015-308329-80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nn.2117","article-title":"Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration","volume":"11","author":"Lagali","year":"2008","journal-title":"Nat Neurosci"},{"key":"key-10.1136\/bjophthalmol-2015-308329-81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.1190897","article-title":"Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa","volume":"329","author":"Busskamp","year":"2010","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-308329-82","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.15252\/emmm.201404077","article-title":"Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter","volume":"6","author":"Cronin","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-83","doi-asserted-by":"crossref","first-page":"16287","DOI":"10.1073\/pnas.1317033110","article-title":"Optogenetics","volume":"110","author":"Williams","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.1136\/bjophthalmol-2015-308329-84","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"},{"key":"key-10.1136\/bjophthalmol-2015-308329-85","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mds.26184","article-title":"Spotlight on movement disorders: what optogenetics has to offer","volume":"30","author":"Rossi","year":"2015","journal-title":"Mov Disord"},{"key":"key-10.1136\/bjophthalmol-2015-308329-86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1606","article-title":"Mitochondrial DNA mutations in human disease","volume":"6","author":"Taylor","year":"2005","journal-title":"Nat Rev Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-87","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMra1012478","article-title":"Monogenic mitochondrial disorders","volume":"366","author":"Koopman","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-88","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrg3966","article-title":"The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease","volume":"16","author":"Stewart","year":"2015","journal-title":"Nat Rev Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-89","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.neuron.2014.11.022","article-title":"Mitochondrial DNA: impacting central and peripheral nervous systems","volume":"84","author":"Carelli","year":"2014","journal-title":"Neuron"},{"key":"key-10.1136\/bjophthalmol-2015-308329-90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7861\/clinmedicine.8-6-601","article-title":"The clinical spectrum of mitochondrial genetic disorders","volume":"8","author":"Kirkman","year":"2008","journal-title":"Clin Med (Lond)"},{"key":"key-10.1136\/bjophthalmol-2015-308329-91","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann Neurol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-92","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.rbmo.2013.08.007","article-title":"Preventing the transmission of mitochondrial DNA disorders: selecting the good guys or kicking out the bad guys","volume":"27","author":"Smeets","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"key-10.1136\/bjophthalmol-2015-308329-93","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1500960","article-title":"Mitochondrial donation\u2014how many women could benefit","volume":"372","author":"Gorman","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-94","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/ng1970","article-title":"The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells","volume":"39","author":"Cao","year":"2007","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/ng.2007.63","article-title":"A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes","volume":"40","author":"Cree","year":"2008","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-96","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/ng.258","article-title":"The mitochondrial DNA genetic bottleneck results from replication of a subpopulation of genomes","volume":"40","author":"Wai","year":"2008","journal-title":"Nat Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-97","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.nmd.2010.05.008","article-title":"174th ENMC International Workshop: applying pre-implantation genetic diagnosis to mtDNA diseases: implications of scientific advances 19-21 March 2010, Naarden, The Netherlands","volume":"20","author":"Poulton","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"key-10.1136\/bjophthalmol-2015-308329-98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2012-101172","article-title":"Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success","volume":"50","author":"Sallevelt","year":"2013","journal-title":"J Med Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-99","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.molmed.2010.04.007","article-title":"Therapeutic prospects for mitochondrial disease","volume":"16","author":"Schon","year":"2010","journal-title":"Trends Mol Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/emmm.201303769","article-title":"A magic bullet to specifically eliminate mutated mitochondrial genomes from patients\u2019 cells","volume":"6","author":"Moraes","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.stem.2015.04.012","article-title":"Converting a problem into an opportunity: mtDNA heteroplasmy shift","volume":"16","author":"Diez-Juan","year":"2015","journal-title":"Cell Stem Cell"},{"key":"key-10.1136\/bjophthalmol-2015-308329-102","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1093\/nar\/gkn313","article-title":"Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA","volume":"36","author":"Minczuk","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"key-10.1136\/bjophthalmol-2015-308329-103","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/gt.2010.25","article-title":"Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease","volume":"17","author":"Bacman","year":"2010","journal-title":"Gene Ther"},{"key":"key-10.1136\/bjophthalmol-2015-308329-104","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","article-title":"Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs","volume":"19","author":"Bacman","year":"2013","journal-title":"Nat Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-105","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/emmm.201303672","article-title":"Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations","volume":"6","author":"Gammage","year":"2014","journal-title":"EMBO Mol Med"},{"key":"key-10.1136\/bjophthalmol-2015-308329-106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2015.03.051","article-title":"Selective elimination of mitochondrial mutations in the germline by genome editing","volume":"161","author":"Reddy","year":"2015","journal-title":"Cell"},{"key":"key-10.1136\/bjophthalmol-2015-308329-107","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-308329-108","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nbt.2884","article-title":"Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype","volume":"32","author":"Yin","year":"2014","journal-title":"Nat Biotechnol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s13238-015-0153-5","article-title":"CRISPR\/Cas9-mediated gene editing in human tripronuclear zygotes","volume":"6","author":"Liang","year":"2015","journal-title":"Protein Cell"},{"key":"key-10.1136\/bjophthalmol-2015-308329-110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nbt.3252","article-title":"The ethics of publishing human germline research","volume":"33","author":"Sharma","year":"2015","journal-title":"Nat Biotechnol"},{"key":"key-10.1136\/bjophthalmol-2015-308329-111","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/hum.2015.28999.tfl","article-title":"Therapeutic germ line alteration: has CRISPR\/Cas9 technology forced the question?","volume":"26","author":"Flotte","year":"2015","journal-title":"Human Gene Therapy"},{"key":"key-10.1136\/bjophthalmol-2015-308329-112","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.aab1028","article-title":"A prudent path forward for genomic engineering and germline gene modification","volume":"348","author":"Baltimore","year":"2015","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2015-308329-113","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature08368","article-title":"Mitochondrial gene replacement in primate offspring and embryonic stem cells","volume":"461","author":"Tachibana","year":"2009","journal-title":"Nature"},{"key":"key-10.1136\/bjophthalmol-2015-308329-114","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature08958","article-title":"Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease","volume":"465","author":"Craven","year":"2010","journal-title":"Nature"},{"key":"key-10.1136\/bjophthalmol-2015-308329-115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature11647","article-title":"Towards germline gene therapy of inherited mitochondrial diseases","volume":"493","author":"Tachibana","year":"2013","journal-title":"Nature"},{"key":"key-10.1136\/bjophthalmol-2015-308329-116","doi-asserted-by":"crossref","first-page":"541","DOI":"10.15252\/embr.201439110","article-title":"Risks inherent to mitochondrial replacement","volume":"16","author":"Morrow","year":"2015","journal-title":"EMBO Rep"},{"key":"key-10.1136\/bjophthalmol-2015-308329-117","doi-asserted-by":"crossref","first-page":"e1004315","DOI":"10.1371\/journal.pgen.1004315","article-title":"The challenges of mitochondrial replacement","volume":"10","author":"Chinnery","year":"2014","journal-title":"PLoS Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-118","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1093\/hmg\/ddr373","article-title":"Mitochondrial DNA disease: new options for prevention","volume":"20","author":"Craven","year":"2011","journal-title":"Hum Mol Genet"},{"key":"key-10.1136\/bjophthalmol-2015-308329-119","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jme.2010.037481","article-title":"Ethics of modifying the mitochondrial genome","volume":"37","author":"Bredenoord","year":"2011","journal-title":"J Med Ethics"},{"key":"key-10.1136\/bjophthalmol-2015-308329-120","doi-asserted-by":"crossref","first-page":"e6651","DOI":"10.1136\/bmj.e6651","article-title":"Nuclear transfer to prevent maternal transmission of mitochondrial DNA disease","volume":"345","author":"Poulton","year":"2012","journal-title":"BMJ"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-308329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:52:41Z","timestamp":1601110361000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-308329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":120,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2016,9,22]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1136\/bjophthalmol-2015-308329"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-308329","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]}}}